arrow
D

Dimitrios Mougiakakos

Otto von Guericke University
H指数:58
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expansion and safety profile of CD28-costimulated anti-CD19 CAR T cells in B-cell lymphoma versus autoimmune disease

CD28共刺激的抗CD19 CAR T细胞在B细胞淋巴瘤与自身免疫性疾病中的扩增及安全性特征

2026-07-080
OAAI
Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy

CAR-T细胞疗法后早期、临床静默性内侧颞叶炎症的证据

2026-07-040
OA
Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia

免疫球蛋白重链状态和基质相互作用塑造慢性淋巴细胞白血病的铁死亡敏感性

2026-01-050
OAAI
Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden

早期CAR T细胞疗法与复发/难治性大B细胞淋巴瘤患者的较低血液毒性负担相关

2025-12-220
OAAI
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement

CAR T-cell疗法可诱导伴有肝胆系统受累的多器官IgG4相关疾病的缓解。

2025-12-080
OAAI
Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse risk

急性移植物抗宿主病发作后高密度脂蛋白水平升高:与T细胞功能障碍和增加复发风险之间的潜在联系

2025-11-030
OAAI
Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

患者特异性的药物基因组学研究表明,xCT是结肠癌中具有预测性的治疗靶点,并可能在肿瘤连接性方面产生潜在影响。

2025-09-240
OAAI
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis

嵌合抗原受体T细胞在抗DAGLA抗体相关脑炎治疗难治性病例中的应用

Med
IF11.8
2025-07-230
OAAI